IBRX

Wall_Solid

I'm there with you holding LPSN, KULR, FFAI, CRML, IBRX, HUMA, BYND, CLOV, OPEN, AIRE and OPEN

primochanka

IBRX reported Q3 results but there is still no volume. Whats happening

ElmoLovesGrover

I saw todays news about the huge sales growth. very impressive. Quick look shows nearly 1 billion shares outstanding and future dilitution almost inevitable. Also pretty strong competition from J&J (TAR-200 looking very good in Phase 2b) for their main drug. Great pipeline for IBRX. Haven't bought in yet, but looking.

Maximum-Tone164

I'm a long time fan of IBRX and though its earnings report was positive, the reason it plunged yesterday is because the negative trial results. If this is not a long play for you, just be mindful that you are not holding a bag.

WaltzZealousideal829

IBRX 🚀🚀🚀 to 4 dollars 

Shwacker51

IBRX is gonna fly today. Outstanding new. Happy I’ve been holding this bag for so long. Hoping to see it reach the $4 range this month

Maximum-Tone164

Be mindful with IBRX. Yes, the report was good and the price has gone up overnight. But remember, why it dumped today. They had disappointing rial results. So, the thing that makes them have good earnings, had bad results. And I say this for someone that has longed for its success. So, just be mindful before going all in.

InterimOccupancy

Buy IBRX in the twos while you still can!

Professional_Task694

IBRX moving overnight. Could be the play tomorrow?

InterimOccupancy

IBRX 🚀🚀🥖🚀

enstantli

Maybe IBRX will be next GameStop

Status-Cover5949

I’m very hopeful for ICU and IBRX

Shwacker51

TNMG is my gamble play. really just bullish on it because I think Asia is a up and coming market and I think this company actually is making moves towards growth. Maybe some big fish will pump it randomly. DFLI will see some movement this month but I will sell the second it reaches a good price point. (Im in @ 1.08) BYND is just my dumb bag. holding it with a prayer that we will see some miracle of a run up in the next 2 months. Will sell it before Christmas unless a miracle happens. NRXP, IXHL, ICU, MBOT, IBRX are my pharma stocks. Long term gambles that I hope pay off. ATCH I am selling this month once the price hits .45. I got in at .23 and made very good profits but just tired of seeing it on my books. ill scalp it again in the future.

Outrageous-Fee4197

$IBRX

GreenCandle666

IBRX

GreenCandle666

IBRX Hasnt made its move yet, but very close. Huge year long decending wedge before break out. Volume quietly accummulating. Your welcome.

GreenCandle666

IBRX Hasnt made its move yet, but very close. Huge year long decending wedge before break out. Volume quietly accummulating. Your welcome.

GreenCandle666

IBRX Hasnt made its move yet, but very close. Huge year long decending wedge before break out. Volume quietly accummulating. Your welcome.

CarelessPhoto4189

IBRX https://preview.redd.it/q250jmrupwxf1.jpeg?width=1179&format=pjpg&auto=webp&s=a95f4efd15b1df37f8980d1d8e2414afc3d63224

CarelessPhoto4189

IBRX https://preview.redd.it/m2wdswnsnwxf1.jpeg?width=1179&format=pjpg&auto=webp&s=51a316d534ef3770eadd931e24600658021d1b81

Rincewind20

IBRX https://finance.yahoo.com/news/immunitybio-ibrx-reports-initial-study-041707356.html

TooSwoleToControl

I'm up 280k. Worst performing stock is IBRX but I'm still holding my bags cuz I think it will pump. PSS doesn't lose

Stockett

Started a post Friday we are using $IBRX to squeeze using the 5 min rule[IBRX](https://www.reddit.com/r/ProjectGME2/s/rUNmE0xDlU)

Stockett

Listen if you guys want to squeeze u need to do the 5 min rule. $IBRX

InterimOccupancy

my IBRX leaps collecting dust c'mon DO SOMETHING

not_the_Cats_Meow

IBRX

CarelessPhoto4189

IBRX. Pretty high SI

Inational_Art

💎🙌 [IBRX] — The Next Big Short Squeeze Nobody’s Ready For 🚀 (My Deep Dive) Alright you beautiful degenerates, I think I just stumbled onto something filthy. Been digging deep into [Ticker IBRX], and what I’m seeing looks like the perfect setup for a short squeeze of biblical proportions. 🧠 Quick Thesis: Insanely high short interest north of 74% on a tiny 98M float, recent ANKTIVA FDA wins lighting a fire under retail while shorts choke on near-100% utilization. And with RFK Jr. now HHS boss draining the big pharma swamp, regulatory roadblocks are crumbling—time to stick it to the suits who’ve been burying actual cancer cures for decades. 💰 The Numbers (aka receipts): • Market Cap: $2.40B • Float: 98.33 million shares • Short Interest: 74.70% (still a beast, even after some covering 🔥) • Days to Cover: 8 • Insider Buying: Yes (117M+ shares scooped up in last 12 months, insiders own 66%+) • Catalyst: Q3 Earnings Nov 12 + sBLA submission for BCG-unresponsive NMIBC + CAR-NK data drop in H2, all supercharged by RFK Jr.’s FDA shakeup greenlighting real innovation over cartel BS 🧨 Why This Screams Short Squeeze: • Shorts are trapped — borrow rates at 1.59% but only 2.6M shares available (utilization ~97%, they’re sweating bullets) • Low float means every buy pushes this thing like a trampoline • Volume drying up = pressure cooker about to blow • Options chain looking spicy AF with call OI stacking heavy at $3 strikes (196K+ contracts total, apes piling in) 📈 Chart Ape Section: Looks like it’s coiling tighter than your ex’s budget. Price hugging above SMA20/50 with RSI at 54 ready to rip higher, and relative volume holding steady quiet before the retail storm hits. 🛡️ RFK Jr. & Regulatory Rage: RFK’s in the HHS hot seat, ally to ImmunityBio founder Soon-Shiong, and he’s got three pipeline apps queued at FDA that big pharma’s been cockblocking. This ain’t just stock plays, it’s apes vs. the machine denying cancer patients real shots at survival. Load up and flip the bird to the denialists; Anktiva’s already saving bladders, next up: lymphoma, glioblastoma, and beyond. Make Cancer Healthy Again 🚀 🧩 Bear Case (because I’m not totally braindead): • Market could nuke everything • Company might dilute (but hey, they just raised clean cash) • Or we could all just be early (and early = wrong in WSB time) 🚨 My Play: • Current Price: Current Price: $2.44 • My Position: 8375k shares • Target: $5 short-term / $10 long-term • Thesis: Shorts have overplayed their hand. All it takes is one spark like RFK fast-tracking that sBLA and this goes full $GME 2.0 mode, curing cancer and crushing hedgies in one glorious moonshot.

Super-Activity-4675

I think it could do that on a normal cycle. If that news is good, I think it will go much more. Their market cap is 240M, and they'd basically get a fast track with the FDA for a leukemia drug that is safer and more effective (at least based on the interim reading) than what's out there. IBRX is a 2B company with a similar product (different cancer). Granted, they're already commercialized, but they got a ton of helium when they got approval. I could see this gapping up 5x with the short pressure if that news is really good. Both are heavily shorted, so a positive read out and a partnership as an example would light a rocket under it. It would still be worth less than IBRX in that scenario. Otherwise, 3ish in the next week or two is probably safe if nothing happens. Bad news is obviously bad news.

Jason__Hardon

Can you please give more details about IBRX? SI%? Float? Price target? Catalyst?

LadyQRex

There are several major BP companies that would love to acquire the IBRX pipeline. With all of its patents, the company should be worth 10x more than what the SP suggests. We have to deal with the shorts first which would give him plenty of leverage in partnership negotiations. In a worst case scenario, he sells and we still win.

tedstickle5

ASST and IBRX - although I hope IBRX has more natural growth

ApprehensiveWar946

IBRX the number one shorted stock

Super-Activity-4675

SLS might an interesting play this week. They are in stage 3 clinical trials for an anti-cancer biologic that treats AML (competing with an 18B drug Keytruda). It also has positive indications for a number of different cancers. They had an interim readout that was very positive, and when the 80th event is read out (any time now), if it's still positive they get a fast track to approval. They have a call on the 29th just after the market opens implying some sort of news. The chart itself looks primed to run up to 3 or maybe 4 on a normal cycle coupled with insider buying and institutions starting to pick them up. I'd say if the news was really good, it should probably hold a similar value to IBRX (which currently sits about 10x higher than their market cap) given they're competing with Keytruda for a different cancer and have similar safety results. Depending on who you read, the short float is between 20 and 40%. I don't know if this is a true squeeze compared to some of the float numbers I see around here, as you're definitely playing the news with some risk, but with that type of short float, the stock has the potential for a violent spike upwards that often happens in this space.

ChristianRauchenwald

Personally, I learned my lesson(s) along the way and didn't invest more than 1% of my portfolio in BYND and closed those using trailing stops with around 4,000% return. That sounds impressive, and as an individual trade it's probably been my best so far, but in absolute dollars that translates to 15 x $1 call options for $150 out of which I closed 5 early for $30 each to recoup my investment and 10 that I closed for $450 each for a total return of $4,500 on my $150 investment. But, being a (greedy) human, I then ended up dropping around $250 on two more $4 calls that are currently worth $30. That said, I'm not entirely certain that BYND is fully done. I can see a scenario where we go down to around $1.50 and from there go up again to at least $8.70 one more time https://preview.redd.it/48qj178xx9xf1.png?width=1539&format=png&auto=webp&s=f196f7de0f26a814577674c430cfdb0af065d4cf There are obviously no guarantees, and this is definitely not financial advice but just my opinion, but I'll be keeping an eye on that, and if I can see turnaround signs at around $1.50 I'll drop at most another 2% of my portfolio in BYND. Besides that I already looked around what else might have potential and got myself the following call options for around 1% of my portfolio each... **Jan. 21st, 2028:** \- WEN $10 \- IBRX $2.50 **Jan. 16th, 2016:** \- RVPH $1 ...and am planning to get myself calls on Monday for: **Dec. or Jan.:** \- AGL $1 **Jan. 2027 or 2028:** \- ASST $17.5 All of those are based on chart patterns and what I (believe I) see on those charts right now. Each of those offers incredible risk/reward ratios so if I'm only right on one of those if would return way more than the cost of all trades combined. It's worth mentioning that IMHO all these trades only make sense in the form of options, due to the relatively small amount required per option and the higher payoff compared to buying the shares each option represents. Anyways, that's my 2cents and plan for now. We'll see how that works out and if I stumble upon anything else during the next couple of weeks. Regarding BYND it's maybe worth mentioning that it would be nice to know the actual short interest right now, to determine if the rally was helped by shorts covering or if shorts simply doubled down and increased their risk, but I doubt I'll get an answer to that question in time, so I'll just watch the chart, as mentioned, for a potential turnaround around $1.50.

osh76

$IBRX could be the next short squeeze with 70% shorted.

ApprehensiveWar946

IBRX is number 1 shorted stock right now

ApprehensiveWar946

IBRX will be next to squeeze, number 1 shorted stock

Interesting_Day_7734

IBRX is a highly shorted stock.

WorkingCall3598

I also sold bynd and rode AIRE from . 97-1.25. then I pussed out. Looking at IBRX now. >70% short

RemiMasso

Revenue growth will be insane. Q3 ER Will be fantastic! $IBRX

RemiMasso

Revenue growth will be insane. Q3 ER Will be fantastic! $IBRX

RemiMasso

Revenue growth will be insane. Q3 ER Will be fantastic! $IBRX

Shwacker51

Made some good money yesterday on DFLI and MVST. MVST is a long term play. Selling that when it buys me a car. DFLI is a 2-6month play for me. Still holding BURU and ATCH because I’m still 100%+ gains on both and have sold the majority of both positions at their peak so letting the rest ride to see if we get some late action. MBOT, IXHL, ICU, IBRX, are ones that I have small positions in just to fuck around and hope they blow up. Still looking for something spicy to end this week strong.

LearningAgain_12025

Thoughts on IBRX squeeze

LifeEfficiency8272

IBRX - at least u won’t loose it all … company has a pipeline. If there phase 3 oncology testing is an efficacious as phase 2 (thru the roof with multiple uses now) could bring u way back beyond ur starting point. Same thing with TMC The Metals Company going after $23.6B in minerals at the bottom of the ocean. They have the boat to do it and ALL their test samples returned beyond expectations potential

LifeEfficiency8272

TMC (the metals company going after deep sea minerals valued at $23.6B) BBAI (mini-palantir) IBRX (oncology w/pipeline, efficacyx100 w/surprising results) MELI (South American oversold “Amazon”)

LifeEfficiency8272

AAYI 10000% … M&A’d to a new ticker and direction sank 80% from $2.50 to $.20 w/in minutes yesterday and def found its bottom today. I doubled down after climbing back 8% today, BUT long way to go bc so ridiculously undervalued. Also loving IBRX - Phase3 oncology upside with established pipeline limiting downside. Exponential Game Changer!!! G’luk :)

LifeEfficiency8272

Wanna get onto ppl’s radar: TCM (the metals company) vessel’s completed sampling found $23.6B in minerals deep sea drilling, next stop … drill baby drill!!! IBRX small profitable oncology pipeline entering expedited Phase 3 trials after thru the roof phase 2 efficacy …. Big possibilities with limited downside! YYAI - M&A yesterday and ridiculously 80% oversold shedding new company shares, bottomed today and climbed back 8% by close with way more to make up! I am holding shares in all 3 …. G’luck all :)

LifeEfficiency8272

Nice job! I wanna share too other ppl’s radars: TCM (the metals company) vessel’s completed sampling found $23.6B in minerals deep sea drilling, next stop … drill baby drill!!! IBRX small profitable oncology pipeline entering expedited Phase 3 trials after thru the roof phase 2 efficacy …. Big possibilities with limited downside! YYAI - M&A yesterday and ridiculously 80% oversold shedding new company shares, bottomed today and climbed back 8% by close with way more to make up! I am holding shares in all 3 …. G’luck all :)

LifeEfficiency8272

TCM (the metals company) vessel’s completed sampling found $23.6B in minerals deep sea drilling, next stop … drill baby drill!!! IBRX small profitable oncology pipeline entering expedited Phase 3 trials after thru the roof phase 2 efficacy …. Big possibilities with limited downside! YYAI - bought yesterday and ridiculously 80% oversold shedding new company shares, bottomed today and climbed back 8% by close with way more to make up! I am holding shares in all 3 …. G’luck all :)

LifeEfficiency8272

I’m hoping I scooped up YYAI after hours last night 🤞🏼 love that call and also IBRX (phase 3 oncology trials underway and results from 2 were thru the roof efficacy). Also TMC the metals company as a moonshot - they’re small company with a big boat looking to do deep sea drilling for $23.6B in minerals

patcakes

Where are my fellow IBRX bag holders at from last year ✋🏻

Embarrassed_Dog_2477

IBRX 🚀🚀🚀🚀🚀

patcakes

IBRX :(

This_Specific7789

IBRX

Kurso

DISCLOSURE: I currently hold 30k shares of $IBRX I’m not sure we’ll see a squeeze on this one. More like, the shorts will just slowly fade away. The company is already FDA approved with rapidly growing revenue. And a single insider owns almost 700M shares (yes outstanding shares is almost 1B), and he’s stated he doesn’t plan to sell it. He wants to turn it into a self sufficient pharma giant. I think this is a great long term hold, but movement on this stock will be earnings based, not some binary event bio short squeeze. This is not financial advice.

blackbeardsballbag

$IBRX is the ticker for anyone wondering

ApprehensiveWar946

I am all in, love IBRX!

ZeboAll123

IBRX is beginning. 39% of the float is short. Short availability is down to 200k from being consistently 1+ million. Price has been going up steadily since mid-august, up about 20%. The company plans to release new research next week, likely catalyzing significant price action🚀

This_Specific7789

A **76.59% short float** makes $IBRX **highly vulnerable to a massive squeeze,** one of the most extreme setups in the market now. If price clears $3 and volume surges, expect **volatile upside**, possibly 100–500% short-term gain potential. This is the next one!

This_Specific7789

A **76.59% short float** makes $IBRX **highly vulnerable to a massive squeeze,** one of the most extreme setups in the market now. If price clears $3 and volume surges, expect **volatile upside**, possibly 100–500% short-term gain potential. This is the next one!

This_Specific7789

A **76.59% short float** makes IBRX **highly vulnerable to a massive squeeze,** one of the most extreme setups in the market now. If price clears $3 and volume surges, expect **volatile upside**, possibly 100–500% short-term gain potential. Better than ORCL

ApprehensiveWar946

That company is IXHL not IBRX, ImmunityBIO

ApprehensiveWar946

Added more IBRX.

EnvironmentalSoft343

Does anyone have any stocks on their radar for the next month? Let's say someone had $2000 to put somewhere, looking to hold for about a month. Any suggestions of stocks that are on your watchlists? Im in PRPH and IBRX, good luck to all!

Super-Activity-4675

IBRX isn't the first bio company that Soon started. There's a reason he's a minority owner of the Lakers. I'm not sure I'd call him useless at business. He knows what he's doing, even if he's not perfect at it. My ex worked for a company like this. Most of them end up bankrupt. IBRX will likely be sold at some point at a number that Soon wants. There are a lot worse companies to be a speculative bag holder, and I saw that as one (though I was lucky and got in at literally their lowest point, so I'm still up close to 100% at the current price.

Final-Boot-4613

Keeping an eye on $IBRX. Someone recently bought the equivalent of a day’s worth of volume

MrEndlessMike

Look at IBRX. FDA approval, sky rocket. Now its sitting at around 2.50

ApprehensiveWar946

I can’t wait for the short squeeze. IBRX on Lung data after close and inevitable FDA label expansion for Anktiva/ Bioshield. https://preview.redd.it/3ufna70swtnf1.jpeg?width=960&format=pjpg&auto=webp&s=11667d419f09e60a5a2ed4b98cfc888ce4e84f3c

snugulupugus

I took the Short Float % from FinViz - [https://elite.finviz.com/quote.ashx?t=IBRX&p=d](https://elite.finviz.com/quote.ashx?t=IBRX&p=d) I took the BLA catalyst dates from BioPharma - [https://biopharmawatch.com/company/IBRX](https://biopharmawatch.com/company/IBRX)

TwinbornMist47

Hopefully this means my IBRX postion goes nuts 

Maximum-Tone164

9/3 watching opening for IBRX, FUBO, HIT, and RMTI. Then will move accordingly.

Whole-Signature-4306

In on $IBRX and $IFRX. Probably just for next week. At least $IFRX had a good day friday

Equivalent_Monk_7215

IBRX

Dizzy-Intention3407

IBRX, primed for squeeze, shorts about to get rekkt 100%

RijnBrugge

The device does nothing but slow cell division. So while I agree with the assessment that we need trial outcomes to tell us whether these people really have a complete response, I must point out that these devices do not cause complete responses in glioblastoma patients. And that is the exact claim already put out by IBRX. As a strategy it makes sense: put the tumor development on pause and then hit it with a immunotherapy and bev which slows the growth of veins to the tumor. I can totally see that cleaning up the tumor effectively, but it will be a while before they have really proven this.

Dizzy-Intention3407

IBRX, time to go up

Dizzy-Intention3407

IBRX, aftermarket move incoming...

RC-5

Thought I read earlier IBRX had the fast track there?

Dizzy-Intention3407

IBRX, delayed reaction short squeeze on news! Ton of shorts about to get rekkt

StockMarketDavid

#IBRX Casually curing cancer and no one cares 💀

StockMarketDavid

#IBRX Literally curing cancer and for some reason markets don't care 😭?

ZeboAll123

IBRX up another percent, so re-commenting this. IBRX short share availability has dropped 90% today. Short interest is at 40%. Already up 6%. Will be next week’s OPEN or TLRY or whatever.

ZeboAll123

IBRX. Short share availability has dropped 90% today. Short interest is at 40%. Already up 5%. Will be next week’s OPEN or TLRY or whatever.

Dizzy-Intention3407

IBRX, news is in!!!

Dizzy-Intention3407

IBRX, all in.

slscoder

IBRX Still have high hopes, just bought too much at a high price.

theweekendr

Roll into IBRX. It’s about to pop very soon $50 plus

Suspicious_Dare_22

IBRX will 🌕this week after phase 1 test success. 🚀

ZeboAll123

IBRX. Up 16% today, 40% of the float is short. Just announced major lymphoma treatment breakthroughs. Perfect for anybody looking for a place to put their BLSH gains.

Bornagainghostbuster

IBRX quietly having a great day, one of the most shorted stocks.

naked_space_chimp

Looks like $IBRX has finally found the cure for cancer... It's up dolla feety sense.

chuckswim

IBRX nice phase 1 result

theweekendr

Anyone in $IBRX

Spedicey007

IBRX looks not to shabby on the long run

skychi

IBRX. This is my gambling account essentially so I just full port into positions.

PuckeringHole

DDD, IBRX, MVIS anyone of these can and will easily has back to $7-$10

PuckeringHole

MVIS, DDD, IBRX easy hold and load at these prices.

Status-Cover5949

I just decided to go long and bought more. There are few stocks like this that impress me with the product, and most won’t pay off well in the short term. I’m big into COSM, ICU, and IBRX. Was a big fan of KULR until they stopped being focused on their battery tech, though I still have a few shares.